# A Study Of Three PF-05190457 Formulations In Healthy Volunteers

> **NCT01522807** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457

## Key facts

- **NCT ID:** NCT01522807
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01522807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01522807, "A Study Of Three PF-05190457 Formulations In Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01522807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*